Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma – effectiveness and treatment reality of the European multi-centric, multi-national, non-interventional study – BERING CRC.

15. Januar 2026

S Stintzing, H Müller-Huesmann, E von der Heyde, I Virchow, R Greil, J Kisro, P Stübs, D Bürkle, A Distelrath, J Wierecky, A Wein, A Gerger, D Arnold, R Fritsch, S Hegewisch-Becker, A Vogel, A Dorothea Wagner, T Winder, D Koeberle, G Prager.

Annals of Oncology, Volume 36, Supplement 1, 2025, Page S25, ISSN 0923-7534, https://doi.org/10.1016/j.annonc.2025.05.052

Abstract